Michael Patrick Pignone, M.D., M.P.H., of the University of North Carolina, Chapel Hill, and colleagues conducted a randomized clinical in October 2011 in which men underwent a values clarification task and then chose the most important attribute for prostate-specific antigen (PSA) screening. Â...
Analyzing prostate-specific antigen (PSA) velocity and its rate of increase over time may help physicians better assess which patients require biopsy and active treatment and could, according to researchers from Innsbruck, Austria, result in significant healthcare savings. These data were...
Analyzing prostate-specific antigen (PSA) velocity and its rate of increase over time may help physicians better assess which patients require biopsy and active treatment and could, according to researchers from Innsbruck, Austria, result in significant healthcare savings. These data were...
UroToday.com - In the Journal of the National Cancer Institute, Dr. Elizabeth Wever and investigators from Rotterdam report that PSA screening in detecting prostate cancer (CaP) was lower in the United States than in the European Randomized Study of Screening for Prostate Cancer-Rotterdam...